NephrologyBeginner

Calcium-Phosphate Product

Assesses the risk of metastatic calcification in renal failure.

Clinical Parameters

2 Variables
mg/dL
mg/dL

Awaiting Clinical Parameters

Configure the patient variables on the left and select Calculate Result to generate the clinical score and stratification.

Verified 2026 GuidelinesInstant Calculation
Jump to Formula & Clinical Protocol ↓
High Yield Prometric TopicNephrology

Tested on Gulf Medical Boards (DHA, SMLE, MOH & HAAD)

Clinical calculations and diagnostic scoring systems like Calcium-Phosphate Product frequently appear on Prometric exams. Master high-yield clinical vignettes with instant AI-powered pathophysiology rationales.

Clinical Significance & Diagnostic Standard
2026 Clinical Reference

What is the Calcium-Phosphate Product?

📋Clinical Summary & Definition Capsule

The Calcium-Phosphate Product is an evidence-based clinical decision rule engineered to quantify diagnostic probability, stratify clinical severity, and guide therapeutic decision-making in nephrology practice. The Calcium-Phosphate Product (Ca × P) is a simple multiplication of serum calcium and serum phosphorus levels. It is used primarily in patients with chronic kidney disease (CKD) to assess the risk of tissue calcification (metastatic calcification and calciphylaxis). Clinical scoring tools like Calcium-Phosphate Product are essential in acute and outpatient management, enabling clinicians to objectively differentiate between low-risk candidates suitable for conservative therapy and high-risk patients requiring urgent interventions. Verified against current 2026 clinical standards, this tool is extensively tested on Gulf health authority licensing exams including DHA (Dubai), SMLE (Saudi Arabia), MOH, HAAD/DOH (Abu Dhabi), OMSB (Oman), and QCHP (Qatar).

💡Clinical Pearls & Diagnostic Utility

While newer KDIGO guidelines emphasize treating individual Ca and P values toward normal ranges, the Ca × P product remains a useful conceptual target and threshold (aiming < 55) for risk-stratifying ESRD patients.

Mathematical Formulation

Formula & Calculation Parameters

The mathematical equation and clinical variables required to calculate Calcium-Phosphate Product:

Ca × P Product = Calcium (mg/dL) × Phosphorus (mg/dL)
Risk Stratification

Score Interpretation & Clinical Stratification

Score RangeClinical InterpretationRisk Tier
≤ 55Low/Acceptable Riskgreen
≥ 55High Risk of Calcificationred
Clinical Limitations & Contraindications

When to Exercise Caution

Both calcium and phosphate must be entered in mg/dL. If the patient is hypoalbuminemic, the corrected calcium should be used for this calculation.

Medical Review & Guidelines Compliance
MD

Clinical Review Board

Dr. Muhammad Nouman, MBBS

Capital Medical University | PMDC Reg No: 117744-P

Clinical Audit Status

✓ Verified for 2026 Guidelines

Last updated: 2026-08-07

Peer-Reviewed Medical Literature

  • Block GA, Klassen PS, Lazarus JM, et al. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol. 2004;15(8):2208-2218.